✉  info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Obesity Management Market Research Report Information By Type (Medications {Orlistat, Lorcaserin, Phentermine and Topiramate, Bupropion and Naltrexone, and Liraglutide}, Surgery {Laparoscopic Adjustable Gastric Banding, Gastric Sleeve and Gastric Bypass} and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Others), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - Forecast Till 2032


ID: MRFR/Pharma/1997-HCR | 90 Pages | Author: Rahul Gotadki| November 2024

Market Segmentation for Obesity Management Market


Obesity Management Type Outlook (USD Billion, 2018-2030)




  • Medications




    • Orlistat




    • Lorcaserin




    • Phentermine and Topiramate




    • Bupropion and Naltrexone




    • Liraglutide






  • Surgery




    • Laparoscopic Adjustable Gastric Band




    • Gastric Sleeve




    • Gastric Bypass






  • Others




Obesity Management Distribution Channel Outlook (USD Billion, 2018-2030)




  • Hospital Pharmacies




  • Retail Pharmacies




  • Others




Obesity Management Regional Outlook (USD Billion, 2018-2030)




  • North America Outlook (USD Billion, 2018-2030)




    • North America Obesity Management by Type




      • Medications




        • Orlistat




        • Lorcaserin




        • Phentermine and Topiramate




        • Bupropion and Naltrexone




        • Liraglutide






      • Surgery




        • Laparoscopic Adjustable Gastric Band




        • Gastric Sleeve




        • Gastric Bypass






      • Others






    • North America Obesity Management by Distribution Channel




      • Hospital Pharmacies




      • Retail Pharmacies




      • Others






    • US Outlook (USD Billion, 2018-2030)




    • US Obesity Management by Type




      • Medications




        • Orlistat




        • Lorcaserin




        • Phentermine and Topiramate




        • Bupropion and Naltrexone




        • Liraglutide






      • Surgery




        • Laparoscopic Adjustable Gastric Band




        • Gastric Sleeve




        • Gastric Bypass






      • Others






    • US Obesity Management by Distribution Channel




      • Hospital Pharmacies




      • Retail Pharmacies




      • Others






    • Canada Outlook (USD Billion, 2018-2030)




    • Canada Obesity Management by Type




      • Medications




        • Orlistat




        • Lorcaserin




        • Phentermine and Topiramate




        • Bupropion and Naltrexone




        • Liraglutide






      • Surgery




        • Laparoscopic Adjustable Gastric Band




        • Gastric Sleeve




        • Gastric Bypass






      • Others






    • Canada Obesity Management by Distribution Channel




      • Hospital Pharmacies




      • Retail Pharmacies




      • Others








  • Europe Outlook (USD Billion, 2018-2030)




    • Europe Obesity Management by Type




      • Medications




        • Orlistat




        • Lorcaserin




        • Phentermine and Topiramate




        • Bupropion and Naltrexone




        • Liraglutide






      • Surgery




        • Laparoscopic Adjustable Gastric Band




        • Gastric Sleeve




        • Gastric Bypass






      • Others






    • Europe Obesity Management by Distribution Channel




      • Hospital Pharmacies




      • Retail Pharmacies




      • Others






    • Germany Outlook (USD Billion, 2018-2030)




    • Germany Obesity Management by Type




      • Medications




        • Orlistat




        • Lorcaserin




        • Phentermine and Topiramate




        • Bupropion and Naltrexone




        • Liraglutide






      • Surgery




        • Laparoscopic Adjustable Gastric Band




        • Gastric Sleeve




        • Gastric Bypass






      • Others






    • Germany Obesity Management by Distribution Channel




      • Hospital Pharmacies




      • Retail Pharmacies




      • Others






    • France Outlook (USD Billion, 2018-2030)




    • France Obesity Management by Type




      • Medications




        • Orlistat




        • Lorcaserin




        • Phentermine and Topiramate




        • Bupropion and Naltrexone




        • Liraglutide






      • Surgery




        • Laparoscopic Adjustable Gastric Band




        • Gastric Sleeve




        • Gastric Bypass






      • Others






    • France Obesity Management by Distribution Channel




      • Hospital Pharmacies




      • Retail Pharmacies




      • Others




      •  






    • UK Outlook (USD Billion, 2018-2030)




    • UK Obesity Management by Type




      • Medications




        • Orlistat




        • Lorcaserin




        • Phentermine and Topiramate




        • Bupropion and Naltrexone




        • Liraglutide






      • Surgery




        • Laparoscopic Adjustable Gastric Band




        • Gastric Sleeve




        • Gastric Bypass






      • Others






    • UK Obesity Management by Distribution Channel




      • Hospital Pharmacies




      • Retail Pharmacies




      • Others






    • Italy Outlook (USD Billion, 2018-2030)




    • Italy Obesity Management by Type




      • Medications




        • Orlistat




        • Lorcaserin




        • Phentermine and Topiramate




        • Bupropion and Naltrexone




        • Liraglutide






      • Surgery




        • Laparoscopic Adjustable Gastric Band




        • Gastric Sleeve




        • Gastric Bypass






      • Others






    • Italy Obesity Management by Distribution Channel




      • Hospital Pharmacies




      • Retail Pharmacies




      • Others














    • Spain Outlook (USD Billion, 2018-2030)




    • Spain Obesity Management by Type




      • Medications




        • Orlistat




        • Lorcaserin




        • Phentermine and Topiramate




        • Bupropion and Naltrexone




        • Liraglutide






      • Surgery




        • Laparoscopic Adjustable Gastric Band




        • Gastric Sleeve




        • Gastric Bypass






      • Others






    • Spain Obesity Management by Distribution Channel




      • Hospital Pharmacies




      • Retail Pharmacies




      • Others






    • Rest Of Europe Outlook (USD Billion, 2018-2030)




    • Rest Of Europe Obesity Management by Type




      • Medications




        • Orlistat




        • Lorcaserin




        • Phentermine and Topiramate




        • Bupropion and Naltrexone




        • Liraglutide






      • Surgery




        • Laparoscopic Adjustable Gastric Band




        • Gastric Sleeve




        • Gastric Bypass






      • Others






    • Rest Of Europe Obesity Management by Distribution Channel




      • Hospital Pharmacies




      • Retail Pharmacies




      • Others







  • Asia-Pacific Outlook (USD Billion, 2018-2030)




    • Asia-Pacific Obesity Management by Type




      • Medications




        • Orlistat




        • Lorcaserin




        • Phentermine and Topiramate




        • Bupropion and Naltrexone




        • Liraglutide






      • Surgery




        • Laparoscopic Adjustable Gastric Band




        • Gastric Sleeve




        • Gastric Bypass






      • Others






    • Asia-Pacific Obesity Management by Distribution Channel




      • Hospital Pharmacies




      • Retail Pharmacies




      • Others














    • China Outlook (USD Billion, 2018-2030)




    • China Obesity Management by Type




      • Medications




        • Orlistat




        • Lorcaserin




        • Phentermine and Topiramate




        • Bupropion and Naltrexone




        • Liraglutide






      • Surgery




        • Laparoscopic Adjustable Gastric Band




        • Gastric Sleeve




        • Gastric Bypass






      • Others






    • China Obesity Management by Distribution Channel




      • Hospital Pharmacies




      • Retail Pharmacies




      • Others






    • Japan Outlook (USD Billion, 2018-2030)




    • Japan Obesity Management by Type




      • Medications




        • Orlistat




        • Lorcaserin




        • Phentermine and Topiramate




        • Bupropion and Naltrexone




        • Liraglutide






      • Surgery




        • Laparoscopic Adjustable Gastric Band




        • Gastric Sleeve




        • Gastric Bypass






      • Others






    • Japan Obesity Management by Distribution Channel




      • Hospital Pharmacies




      • Retail Pharmacies




      • Others






    • India Outlook (USD Billion, 2018-2030)




    • India Obesity Management by Type




      • Medications




        • Orlistat




        • Lorcaserin




        • Phentermine and Topiramate




        • Bupropion and Naltrexone




        • Liraglutide






      • Surgery




        • Laparoscopic Adjustable Gastric Band




        • Gastric Sleeve




        • Gastric Bypass






      • Others






    • India Obesity Management by Distribution Channel




      • Hospital Pharmacies




      • Retail Pharmacies




      • Others






    • South Korea Outlook (USD Billion, 2018-2030)




    • South Korea Obesity Management by Type




      • Medications




        • Orlistat




        • Lorcaserin




        • Phentermine and Topiramate




        • Bupropion and Naltrexone




        • Liraglutide






      • Surgery




        • Laparoscopic Adjustable Gastric Band




        • Gastric Sleeve




        • Gastric Bypass






      • Others






    • South Korea Obesity Management by Distribution Channel




      • Hospital Pharmacies




      • Retail Pharmacies




      • Others






    • Australia Outlook (USD Billion, 2018-2030)




    • Australia Obesity Management by Type




      • Medications




        • Orlistat




        • Lorcaserin




        • Phentermine and Topiramate




        • Bupropion and Naltrexone




        • Liraglutide






      • Surgery




        • Laparoscopic Adjustable Gastric Band




        • Gastric Sleeve




        • Gastric Bypass






      • Others






    • Australia Obesity Management by Distribution Channel




      • Hospital Pharmacies




      • Retail Pharmacies




      • Others






    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2030)




    • Rest of Asia-Pacific Obesity Management by Type




      • Medications




        • Orlistat




        • Lorcaserin




        • Phentermine and Topiramate




        • Bupropion and Naltrexone




        • Liraglutide






      • Surgery




        • Laparoscopic Adjustable Gastric Band




        • Gastric Sleeve




        • Gastric Bypass






      • Others






    • Rest of Asia-Pacific Obesity Management by Distribution Channel




      • Hospital Pharmacies




      • Retail Pharmacies




      • Others







  • Rest of the World Outlook (USD Billion, 2018-2030)




    • Rest of the World Obesity Management by Type




      • Medications




        • Orlistat




        • Lorcaserin




        • Phentermine and Topiramate




        • Bupropion and Naltrexone




        • Liraglutide






      • Surgery




        • Laparoscopic Adjustable Gastric Band




        • Gastric Sleeve




        • Gastric Bypass






      • Others






    • Rest of the World Obesity Management by Distribution Channel




      • Hospital Pharmacies




      • Retail Pharmacies




      • Others














    • Middle East Outlook (USD Billion, 2018-2030)




    • Middle East Obesity Management by Type




      • Medications




        • Orlistat




        • Lorcaserin




        • Phentermine and Topiramate




        • Bupropion and Naltrexone




        • Liraglutide






      • Surgery




        • Laparoscopic Adjustable Gastric Band




        • Gastric Sleeve




        • Gastric Bypass






      • Others






    • Middle East Obesity Management by Distribution Channel




      • Hospital Pharmacies




      • Retail Pharmacies




      • Others






    • Africa Outlook (USD Billion, 2018-2030)




    • Africa Obesity Management by Type




      • Medications




        • Orlistat




        • Lorcaserin




        • Phentermine and Topiramate




        • Bupropion and Naltrexone




        • Liraglutide






      • Surgery




        • Laparoscopic Adjustable Gastric Band




        • Gastric Sleeve




        • Gastric Bypass






      • Others






    • Africa Obesity Management by Distribution Channel




      • Hospital Pharmacies




      • Retail Pharmacies




      • Others






    • Latin America Outlook (USD Billion, 2018-2030)




    • Latin America Obesity Management by Type




      • Medications




        • Orlistat




        • Lorcaserin




        • Phentermine and Topiramate




        • Bupropion and Naltrexone




        • Liraglutide






      • Surgery




        • Laparoscopic Adjustable Gastric Band




        • Gastric Sleeve




        • Gastric Bypass






      • Others






    • Latin America Obesity Management by Distribution Channel




      • Hospital Pharmacies




      • Retail Pharmacies




      • Others






Research Methodology on Obesity Management Market


Market Research Future (MRFR) has conducted extensive research for its report on the global obesity management market and relied on secondary and primary research. In the report, analysts of MRFR have used Porter’s Five Force Model and have taken into account numerous industry trends and dynamics. MRFR has also included a SWOT analysis in the report.    


Secondary Research


MRFR conducted secondary research to gain a thorough understanding of the market size, forecast and trends. Secondary research sources used included analyst reports, government databases and websites, industry associations, journals and other data sources such as Bloomberg, Hoovers, Factiva and Datamonitor, particularly in emerging markets. We have triangulated the data gather via secondary sources with primary sources to gain further insights into the global obesity management market.


Primary Research


Primary research is essential for understanding and verifying the market data gathered via secondary research. Market experts and industry leaders are consulted to prepare the market report. An interview guide is prepared for taking in-depth insights from industry experts and for validating the data gathered via secondary research.


Computer-Aided Design (CAD)


MRFR is using CAD (Computer Aided Design) in its reports. Computer-Aided Design is a novel and most recent research method that helps in creating accurate information from the data acquired from secondary and primary sources. This helps in creating accurate, powerful and effective information models. Based on various parameters such as investments, costs, return on investments, market share, sales and growth rate, CAD helps in creating highly authentic and reliable market reports.


Market Data Validation


MRFR uses highly advanced and reliable techniques to validate market data. Market experts and industry leaders are consulted throughout the market data validation process to ensure the accuracy of the data gathered and analyzed. This helps in creating a highly reliable and robust market report. Based on certain assumptions and hypotheses, the market report prepared by MRFR is also checked and cross-checked.


Analysis Used


MRFR makes use of various analytical techniques and types of analysis to understand the dynamic of the global obesity management market. The analytical techniques used include Porter’s Five Force Model, SWOT Analysis, and Linear Regression Analysis. These techniques cover the entire market under study, covering the macro and the microenvironment.


Porter’s Five Force Model


MRFR makes use of Porter’s Five Force Model to analyze competitive trends among the leading players in the global obesity management market. According to this study, the bargaining power of suppliers, threat of new entrants, bargaining power of buyers, threat of substitutes and degree of competition in the market are studied to understand the competitive trends in the market.


SWOT Analysis


MRFR makes use of SWOT Analysis in its report to understand the strengths, weaknesses, opportunities, and threats involved in the global obesity management market. This method helps MRFR to identify and understand the responses to internal and external factors in the market.


Linear Regression Analysis


Linear regression analysis is done by MRFR to predict the trend in the market. This analysis helps in understanding the historic factors which impact the market and provides information about past, current and future trends in the market. The analysis helps in estimating the total revenue in the global obesity management market and also provides information about the market size of the segment.


The final report is a comprehensive compilation of the research and analysis conducted by MRFR during its research process and gives an accurate picture of the global obesity management market. These data can be used by the market players to create strategies, formulate policies and roadmaps, and make decisions relating to the market and the industry in general.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

Table of Contents

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

6. GLOBAL OBESITY MANAGEMENT MARKET, BY TYPE

6.1. Overview

6.2. Medication

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.1. Orlistat

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.2. Lorcaserin

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.3. Phentermine and topiramate

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.4. Bupropion and naltrexone

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.5. Liraglutide

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3. Surgery

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.1. Laparoscopic Adjustable Gastric Band

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.2. Gastric Sleeve

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.3. Gastric Bypass

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7. GLOBAL OBESITY MANAGEMENT MARKET, BY REGION

7.1. Overview

7.2. Americas

7.2.1. North America

7.2.1.1. US

7.2.1.2. Canada

7.2.2. Latin America

7.3. Europe

7.3.1. Western Europe

7.3.1.1. Germany

7.3.1.2. France

7.3.1.3. Italy

7.3.1.4. Spain

7.3.1.5. UK

7.3.1.6. Rest of Western Europe

7.3.2. Eastern Europe

7.4. Asia-Pacific

7.4.1. Japan

7.4.2. China

7.4.3. India

7.4.4. Australia

7.4.5. South Korea

7.4.6. Rest of Asia-Pacific

7.5. Middle East & Africa

7.5.1. Middle East

7.5.2. Africa

8. COMPANY LANDSCAPE

8.1. Overview

8.2. Competitive Analysis

8.3. Market Share Analysis

8.4. Major Growth Strategy in the Global Obesity Management Market

8.5. Competitive Benchmarking

8.6. Leading Players in Terms of the Number of Developments in the Global Obesity Management Market

8.7. Key Developments and Growth Strategies

8.7.1. New Application Launch/Service Deployment

8.7.2. Mergers and Acquisitions

8.7.3. Joint Ventures

8.8. Major Players Financial Matrix & Market Ratio

8.8.1. Sales & Operating Income 2020

8.8.2. Major Players R&D Expenditure 2020

8.9. Major Players Capital Market Ratio

9. COMPANY PROFILES

9.1. Pfizer Inc.

9.1.1. Company Overview

9.1.2. Application Type Overview

9.1.3. Financial Overview

9.1.4. Key Developments

9.1.5. SWOT Analysis

9.1.6. Key Strategies

9.2. Merck Sharp & Dohme Corp.

9.2.1. Company Overview

9.2.2. Application Type Overview

9.2.3. Financial Overview

9.2.4. Key Developments

9.2.5. SWOT Analysis

9.2.6. Key Strategies

9.3. F. Hoffmann-La Roche Ltd

9.3.1. Company Overview

9.3.2. Application Type Overview

9.3.3. Financial Overview

9.3.4. Key Developments

9.3.5. SWOT Analysis

9.3.6. Key Strategies

9.4. GlaxoSmithKline plc.

9.4.1. Company Overview

9.4.2. Application Type Overview

9.4.3. Financial Overview

9.4.4. Key Developments

9.4.5. SWOT Analysis

9.4.6. Key Strategies

9.5. AstraZeneca

9.5.1. Company Overview

9.5.2. Application Type Overview

9.5.3. Financial Overview

9.5.4. Key Developments

9.5.5. SWOT Analysis

9.5.6. Key Strategies

9.6. Herbalife Ltd.

9.6.1. Company Overview

9.6.2. Application Type Overview

9.6.3. Financial Overview

9.6.4. Key Developments

9.6.5. SWOT Analysis

9.6.6. Key Strategies

9.7. Apollo Endosurgery

9.7.1. Company Overview

9.7.2. Application Type Overview

9.7.3. Financial Overview

9.7.4. Key Developments

9.7.5. SWOT Analysis

9.7.6. Key Strategies

9.8. Ethicon, Inc.

9.8.1. Company Overview

9.8.2. Application Type Overview

9.8.3. Financial Overview

9.8.4. Key Developments

9.8.5. SWOT Analysis

9.8.6. Key Strategies

9.9. Others

10. APPENDIX

10.1. References

10.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL OBESITY MANAGEMENT MARKET SYNOPSIS, 2020-2027

TABLE 2 GLOBAL OBESITY MANAGEMENT MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)

TABLE 3 GLOBAL OBESITY MANAGEMENT MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 4 GLOBAL OBESITY MANAGEMENT MARKET, BY REGION, 2020-2027 (USD MILLION)

TABLE 5 NORTH AMERICA: OBESITY MANAGEMENT MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 6 US: OBESITY MANAGEMENT MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 7 CANADA: OBESITY MANAGEMENT MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 8 LATIN AMERICA: OBESITY MANAGEMENT MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 9 EUROPE: OBESITY MANAGEMENT MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 10 WESTERN EUROPE: OBESITY MANAGEMENT MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 11 EASTERN EUROPE: OBESITY MANAGEMENT MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 12 ASIA-PACIFIC: OBESITY MANAGEMENT MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 13 MIDDLE EAST & AFRICA: OBESITY MANAGEMENT MARKET, BY TYPE, 2020-2027 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCES

FIGURE 2 MARKET STRUCTURE OF THE GLOBAL OBESITY MANAGEMENT MARKET

FIGURE 3 MARKET DYNAMICS OF THE GLOBAL OBESITY MANAGEMENT MARKET

FIGURE 4 GLOBAL OBESITY MANAGEMENT MARKET SHARE, BY TYPE, 2020 (%)

FIGURE 5 GLOBAL OBESITY MANAGEMENT MARKET SHARE, BY REGION, 2020 (%)

FIGURE 7 AMERICAS: OBESITY MANAGEMENT MARKET SHARE BY REGION, 2020 (%)

FIGURE 6 NORTH AMERICA: OBESITY MANAGEMENT MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 7 EUROPE: OBESITY MANAGEMENT MARKET SHARE, BY REGION, 2020 (%)

FIGURE 8 WESTERN EUROPE: OBESITY MANAGEMENT MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 9 ASIA-PACIFIC: OBESITY MANAGEMENT MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 10 MIDDLE EAST & AFRICA: OBESITY MANAGEMENT MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 11 GLOBAL OBESITY MANAGEMENT MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 12 PFIZER INC.: KEY FINANCIALS

FIGURE 13 PFIZER INC.: SEGMENTAL REVENUE

FIGURE 14 PFIZER INC.: REGIONAL REVENUE

FIGURE 15 MERCK SHARP & DOHME CORP.

FIGURE 16 F. HOFFMANN-LA ROCHE LTD

FIGURE 17 GLAXOSMITHKLINE PLC.

FIGURE 18 ASTRAZENECA

FIGURE 19 HERBALIFE LTD.

FIGURE 20 APOLLO ENDOSURGERY

FIGURE 21 ETHICON, INC.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Related Reports
report-img
Laparoscopy Devices Market Research Report - Global Forecast till 2032
Press Release
pr-img
Global Obesity Management Market Proliferate Relentlessly; Asserts MRFR Unleashing Industry Forec...
Logo
Dmca Cloudflare ssl
Paypal footer Ssl
Services Industry Expertise Consulting Services Articles How To Order FAQs
Our Company About US Careers Contact Us Terms & Conditions Privacy Policy
Banking Partners
Amex Mastercard1
Razerpay
Hdfcbank
Visa
✉  info@marketresearchfuture.com
📞  +1 (855) 661-4441(US)
📞  +44 1720 412 167(UK)

© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)